Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence

被引:23
作者
Elman, I
Breiter, HC
Gollub, RL
Krause, S
Kantor, HL
Baumgartner, WA
Gastfriend, DR
Rosen, BR
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, Addict Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Radiol, Nucl Magnet Resonance Ctr, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA
[5] W Los Angeles Vet Adm Med Ctr, Los Angeles, CA USA
[6] Univ So Calif, Sch Pharm, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
cocaine; hypothalamic-pituitary-adrenal axis; clinical pharmacology; depression; comorbidity; endocrinology;
D O I
10.1016/S0376-8716(99)00009-5
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The hypothalamic-pituitary-adrenal (HPA) axis plays a role in cocaine dependence and major depressive disorder. The authors examined the correlation between baseline depressive symptomatology and pituitary-adrenal axis activation induced by acute cocaine challenge. Twelve patients with cocaine dependence were administered an iv bolus of cocaine (0.6 mg/kg) and their plasma was assayed for levels of adrenocorticotropic hormone (ACTH) and cortisol. Depressive symptomatology was assessed with total Hamilton rating scale for depression (HRSD) scores and its vegetative and cognitive superfactors. Cocaine produced a mean increase from baseline of 261% for ACTH and 73% for cortisol plasma levels. Changes in ACTH (r = 0.69) and cortisol (r = 0.59) were positively and significantly correlated with total HRSD scores and its vegetative, but not cognitive, factor symptom cluster. These results suggest that the HPA axis may be involved in affective disturbances associated with the use of cocaine. Implications of these data for the pathophysiology of cocaine dependence are discussed. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 49 条
[11]   NEURO-ENDOCRINE FINDINGS IN CHRONIC COCAINE ABUSERS - A PRELIMINARY-REPORT [J].
GAWIN, FH ;
KLEBER, HD .
BRITISH JOURNAL OF PSYCHIATRY, 1985, 147 (NOV) :569-573
[12]   A neuroendocrine role in cocaine reinforcement [J].
Goeders, NE .
PSYCHONEUROENDOCRINOLOGY, 1997, 22 (04) :237-259
[13]   Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs [J].
Gold, PW ;
Licinio, J ;
Wong, ML ;
Chrousos, GP .
STRESS: BASIC MECHANISMS AND CLINICAL IMPLICATIONS, 1995, 771 :716-729
[14]   DIFFERENTIAL REGULATION OF BRAIN AND PITUITARY CORTICOTROPIN-RELEASING FACTOR RECEPTORS BY CORTICOSTERONE [J].
HAUGER, RL ;
MILLAN, MA ;
CATT, KJ ;
AGUILERA, G .
ENDOCRINOLOGY, 1987, 120 (04) :1527-1533
[15]  
Ho AP, 1996, ARCH GEN PSYCHIAT, V53, P645
[16]   REPEATED ADMINISTRATION OF THE COMBINED DEXAMETHASONE-HUMAN CORTICOTROPIN RELEASING HORMONE STIMULATION TEST DURING TREATMENT OF DEPRESSION [J].
HOLSBOERTRACHSLER, E ;
STOHLER, R ;
HATZINGER, M .
PSYCHIATRY RESEARCH, 1991, 38 (02) :163-171
[17]   THE ROLE OF THE HIPPOCAMPUS IN FEEDBACK-REGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL AXIS [J].
JACOBSON, L ;
SAPOLSKY, R .
ENDOCRINE REVIEWS, 1991, 12 (02) :118-134
[18]   The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children [J].
Kaufman, J ;
Birmaher, B ;
Perel, J ;
Dahl, RE ;
Moreci, P ;
Nelson, B ;
Wells, W ;
Ryan, ND .
BIOLOGICAL PSYCHIATRY, 1997, 42 (08) :669-679
[19]   CORTICOSTEROID INHIBITION OF ACTH-SECRETION [J].
KELLERWOOD, ME ;
DALLMAN, MF .
ENDOCRINE REVIEWS, 1984, 5 (01) :1-24
[20]   MONOAMINERGIC REGULATION OF NEUROENDOCRINE FUNCTION AND ITS MODIFICATION BY COCAINE [J].
LEVY, AD ;
BAUMANN, MH ;
VANDEKAR, LD .
FRONTIERS IN NEUROENDOCRINOLOGY, 1994, 15 (02) :85-156